Clinical Trials Browser

NIH × Neuroectodermal Tumors, Primitive, Peripheral × talazoparib × Clear all

NCT02116777 2021-03-26

Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies

Phase 1/2 Completed

40 enrolled 32 charts

Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral